6-(ETHYNYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
申请人:Afraxis, Inc.
公开号:EP2580217A2
公开(公告)日:2013-04-17
US8957235B2
申请人:——
公开号:US8957235B2
公开(公告)日:2015-02-17
[EN] 6-(ETHYNYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS<br/>[FR] 6-(ÉTHYNYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES POUR LE TRAITEMENT DE TROUBLES DU SNC
申请人:AFRAXIS INC
公开号:WO2011156786A2
公开(公告)日:2011-12-15
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.